BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 22917220)

  • 1. Vaccinia virus-mediated intra-tumoral expression of matrix metalloproteinase 9 enhances oncolysis of PC-3 xenograft tumors.
    Schäfer S; Weibel S; Donat U; Zhang Q; Aguilar RJ; Chen NG; Szalay AA
    BMC Cancer; 2012 Aug; 12():366. PubMed ID: 22917220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regression of human prostate tumors and metastases in nude mice following treatment with the recombinant oncolytic vaccinia virus GLV-1h68.
    Gentschev I; Donat U; Hofmann E; Weibel S; Adelfinger M; Raab V; Heisig M; Chen N; Yu YA; Stritzker J; Szalay AA
    J Biomed Biotechnol; 2010; 2010():489759. PubMed ID: 20379368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth inhibition of different human colorectal cancer xenografts after a single intravenous injection of oncolytic vaccinia virus GLV-1h68.
    Ehrig K; Kilinc MO; Chen NG; Stritzker J; Buckel L; Zhang Q; Szalay AA
    J Transl Med; 2013 Mar; 11():79. PubMed ID: 23531320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferential colonization of metastases by oncolytic vaccinia virus strain GLV-1h68 in a human PC-3 prostate cancer model in nude mice.
    Donat U; Weibel S; Hess M; Stritzker J; Härtl B; Sturm JB; Chen NG; Gentschev I; Szalay AA
    PLoS One; 2012; 7(9):e45942. PubMed ID: 23049897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient colonization and therapy of human hepatocellular carcinoma (HCC) using the oncolytic vaccinia virus strain GLV-1h68.
    Gentschev I; Müller M; Adelfinger M; Weibel S; Grummt F; Zimmermann M; Bitzer M; Heisig M; Zhang Q; Yu YA; Chen NG; Stritzker J; Lauer UM; Szalay AA
    PLoS One; 2011; 6(7):e22069. PubMed ID: 21779374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replication efficiency of oncolytic vaccinia virus in cell cultures prognosticates the virulence and antitumor efficacy in mice.
    Chen NG; Yu YA; Zhang Q; Szalay AA
    J Transl Med; 2011 Sep; 9():164. PubMed ID: 21951588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression of human pancreatic tumor xenografts in mice after a single systemic injection of recombinant vaccinia virus GLV-1h68.
    Yu YA; Galanis C; Woo Y; Chen N; Zhang Q; Fong Y; Szalay AA
    Mol Cancer Ther; 2009 Jan; 8(1):141-51. PubMed ID: 19139123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eradication of solid human breast tumors in nude mice with an intravenously injected light-emitting oncolytic vaccinia virus.
    Zhang Q; Yu YA; Wang E; Chen N; Danner RL; Munson PJ; Marincola FM; Szalay AA
    Cancer Res; 2007 Oct; 67(20):10038-46. PubMed ID: 17942938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccinia virus-mediated expression of human erythropoietin in tumors enhances virotherapy and alleviates cancer-related anemia in mice.
    Nguyen DH; Chen NG; Zhang Q; Le HT; Aguilar RJ; Yu YA; Cappello J; Szalay AA
    Mol Ther; 2013 Nov; 21(11):2054-62. PubMed ID: 23765443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncolytic vaccinia virus GLV-1h68 strain shows enhanced replication in human breast cancer stem-like cells in comparison to breast cancer cells.
    Wang H; Chen NG; Minev BR; Szalay AA
    J Transl Med; 2012 Aug; 10():167. PubMed ID: 22901246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination treatment with oncolytic Vaccinia virus and cyclophosphamide results in synergistic antitumor effects in human lung adenocarcinoma bearing mice.
    Hofmann E; Weibel S; Szalay AA
    J Transl Med; 2014 Jul; 12():197. PubMed ID: 25030093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccinia virus GLV-1h237 carrying a Walker A motif mutation of mouse Cdc6 protein enhances human breast tumor therapy in mouse xenografts.
    Hofmann E; Grummt F; Szalay AA
    Int J Oncol; 2011 Mar; 38(3):871-8. PubMed ID: 21249314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virotherapy of canine tumors with oncolytic vaccinia virus GLV-1h109 expressing an anti-VEGF single-chain antibody.
    Patil SS; Gentschev I; Adelfinger M; Donat U; Hess M; Weibel S; Nolte I; Frentzen A; Szalay AA
    PLoS One; 2012; 7(10):e47472. PubMed ID: 23091626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral-mediated oncolysis is the most critical factor in the late-phase of the tumor regression process upon vaccinia virus infection.
    Weibel S; Raab V; Yu YA; Worschech A; Wang E; Marincola FM; Szalay AA
    BMC Cancer; 2011 Feb; 11():68. PubMed ID: 21320309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of GLV-1h68 for Vaccinia Virotherapy and Monitoring.
    Frentzen A; Geissinger U; Tsoneva D; Stritzker J
    Methods Mol Biol; 2015; 1317():225-37. PubMed ID: 26072410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant vaccinia virus GLV-1h68 is a promising oncolytic vector in the treatment of cholangiocarcinoma.
    Pugalenthi A; Mojica K; Ady JW; Johnsen C; Love D; Chen NG; Aguilar RJ; Szalay AA; Fong Y
    Cancer Gene Ther; 2015 Dec; 22(12):591-6. PubMed ID: 26584530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncolytic vaccinia virus as a vector for therapeutic sodium iodide symporter gene therapy in prostate cancer.
    Mansfield DC; Kyula JN; Rosenfelder N; Chao-Chu J; Kramer-Marek G; Khan AA; Roulstone V; McLaughlin M; Melcher AA; Vile RG; Pandha HS; Khoo V; Harrington KJ
    Gene Ther; 2016 Apr; 23(4):357-68. PubMed ID: 26814609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical evaluation of oncolytic vaccinia virus for therapy of canine soft tissue sarcoma.
    Gentschev I; Adelfinger M; Josupeit R; Rudolph S; Ehrig K; Donat U; Weibel S; Chen NG; Yu YA; Zhang Q; Heisig M; Thamm D; Stritzker J; Macneill A; Szalay AA
    PLoS One; 2012; 7(5):e37239. PubMed ID: 22615950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of fractionated irradiation with anti-VEGF expressing vaccinia virus therapy enhances tumor control by simultaneous radiosensitization of tumor associated endothelium.
    Buckel L; Advani SJ; Frentzen A; Zhang Q; Yu YA; Chen NG; Ehrig K; Stritzker J; Mundt AJ; Szalay AA
    Int J Cancer; 2013 Dec; 133(12):2989-99. PubMed ID: 23729266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic cytotoxicity of radiation and oncolytic Lister strain vaccinia in (V600D/E)BRAF mutant melanoma depends on JNK and TNF-α signaling.
    Kyula JN; Khan AA; Mansfield D; Karapanagiotou EM; McLaughlin M; Roulstone V; Zaidi S; Pencavel T; Touchefeu Y; Seth R; Chen NG; Yu YA; Zhang Q; Melcher AA; Vile RG; Pandha HS; Ajaz M; Szalay AA; Harrington KJ
    Oncogene; 2014 Mar; 33(13):1700-12. PubMed ID: 23624923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.